Enhanced Investments - Financial Portal

ReShape Lifesciences™ to Host Exhibit at Bariatric Summit

Published: 2021-09-13 12:00:00 ET

ReShape Director of reshapecare™ Heather Mackie will be speaking at the conference

SAN CLEMENTE, Calif., Sept. 13, 2021 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss solutions company, today announced the company will host an exhibit at the upcoming 17th Annual Bariatric Summit in Washington, D.C.September 18-19, 2021. ReShape Senior Director of reshapecare™Heather Mackie, MS, RDN, LD will be presenting and participating in focal patient care sessions during the conference.

“We look forward to engaging in actionable discussions among the prestigious physician and integrated health community members at the upcoming Bariatric Summit. Additionally, we are excited to discuss our mission to help minimize obesity-related conditions using our integrated product and digital health portfolio that addresses therapeutic and wellness-oriented weight loss regimens. We encourage participants to attend Heather’s presentations and visit our exhibit to learn more about ReShape’s Physician-Led Weight Loss Solutions and forward strategy,” commented Bart Bandy, President and Chief Executive Officer at ReShape Lifesciences.

ReShape’s exhibit can be found at the Washington Marriott at Metro Center in Washington, D.C. starting Saturday, September 18th at 9:25 am ET through Sunday, September 19th at 10 am ET.

The details of Heather Mackie’s participation include:

Title: Intractable Vitamin Deficiencies After Duodenal SwitchDate and Time: Saturday, September 18, 2021, 1:45 – 2:00 pm ETLocation: Washington Marriott at Metro Center in Washington, D.C.

Title: Panel DiscussionDate and Time: Saturday, September 18, 2021, 3:15 – 3:30 pm ETLocation: Washington Marriott at Metro Center in Washington, D.C

Moderator: Session 4 – Useful Knowledge for all DisciplinesDate and Time: Saturday, September 18, 2021, 4:00 – 6:00 pm ETLocation: Washington Marriott at Metro Center in Washington, D.C.

Title: What Should I Eat (with co-speaker Kellene Isom, PhD, MS, RD, CAGS)Date and Time: Sunday, September 19, 2021, 8:00-8:15am ETLocation: Washington Marriott at Metro Center in Washington, D.C.

Title: Troubleshooting Vitamin and Mineral RecommendationsDate and Time: Sunday, September 19, 2021, 8:45 – 9:00 am ETLocation: Washington Marriott at Metro Center in Washington, D.C.

Title: Panel Discussion / Q&ADate and Time: Sunday, September 19, 2021, 9:15 – 9:30 am ETLocation: Washington Marriott at Metro Center in Washington, D.C.

ABOUT RESHAPE LIFESCIENCES INC.

ReShape Lifesciences™ is America's premier weight loss and metabolic health-solutions company, offering an integrated portfolio of proven products and services that manage and treat obesity and metabolic disease. The FDA-approved Lap-Band® Program provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures such as the gastric bypass or sleeve gastrectomy. The ReShape Vest™ System is an investigational (outside the U.S.) minimally invasive, laparoscopically implanted medical device that wraps around the stomach, emulating the gastric volume reduction effect of conventional weight-loss surgery. It helps enable rapid weight loss in obese and morbidly obese patients without permanently changing patient anatomy. reshapecare™ is a virtual weight-management program that supports lifestyle changes for all weight-loss patients led by board certified health coaches to help them keep the weight off over time. The recently launched ReShape Marketplace™ is an online collection of quality wellness products curated for all consumers to help them achieve their health goals.

Forward-Looking Safe Harbor Statement:

This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by the use of words such as "expect," "plan," "anticipate," "could," "may," "intend," "will," "continue," "future," other words of similar meaning and the use of future dates. Forward-looking statements in this press release include statements about our commitment to establishing ReShape Lifesciences as the predominant access source for best-in-class weight loss pathways, products and services. These forward-looking statements are based on the current expectations of our management and involve known and unknown risks and uncertainties that may cause our actual results, performance, or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. These risks and uncertainties are described more fully in the Company's filings with the Securities and Exchange Commission, particularly those factors identified as "risk factors" in our annual report on Form 10-K filed March 11, 2021. We are providing this information as of the date of this press release and do not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise, except as required by law.

CONTACTS:

ReShape Lifesciences Investor Contact: Thomas StankovichChief Financial Officer949-276-6042ir@ReShapeLifesci.com

Investor Contacts:Daniel Kontoh-Boateng Assistant Vice President The Ruth Group646-536-7019dboateng@theruthgroup.com

Source: ReShape Lifesciences Inc

Enhanced Investments, Inc.
329 South Oyster Bay Road #2085
Plainview, NY 11803
team@eninvs.com

Important disclosures

Performance results were prepared by Enhanced Investments, and have not been compiled, reviewed or audited by an independent accountant. Performance estimates are subject to future adjustment and revision. Investors should be aware that a loss of investment is possible. Account holdings are for illustrative purposes only and are not investment recommendations. Additional information, including (i) the calculation methodology; and (ii) a list showing the contribution of each holding to the portfolio’s performance during the time period will be provided upon request.
All statements made via social media sites sponsored or maintained by Enhanced Investments and its affiliates are for informational purposes only and do not constitute a comprehensive description of Enhanced Investments' investment advisory services.
Certain investments are not suitable for all investors. Before investing, consider your investment objectives and applicable fees. The rate of return on investments can vary widely over time, especially for long term investments. Investment losses are possible, including the potential loss of all amounts invested. Information provided by Enhanced Investments is for informational and general educational purposes only and is not investment or financial advice.

Nothing on this website should be considered an offer, solicitation of an offer, or advice to buy or sell securities.
Past performance is no guarantee of future results. Any historical returns, expected returns [or probability projections] are hypothetical in nature and may not reflect actual future performance.
All the strategies assume investments in equity invstrumenta only and are more relevant for "agressive investment profile". Eastern European flagship strategy assumes using up to 20% leverage of total portfolio. GlobalCommodities and US Growth strategy currently assume no leverage.
Results for the Enhanced Investments strategies as compared to the performance of Illustrative Benchmarks is for informational purposes only. Our investment program does not mirror that of the Illustrative Benchmarks and the volatility may be materially different from the volatility of Illustrative Benchmarks. Reference or comparison to an Illustrative Benchmark does not imply that strategies of Enhanced Investments will be constructed in the same way as the Illustrative Benchmark or achieve returns, volatility, or other results similar to those of the Illustrative Benchmark. The S&P 500 is an unmanaged market capitalization-weighted index of 500 common stocks chosen for market size, liquidity, and industry group representation to represent U.S. equity performance.
Performance results were prepared by Enhanced Investments, and have not been compiled, reviewed or audited by an independent accountant. Performance estimates are subject to future adjustment and revision. Investors should be aware that a loss of investment is possible. Account holdings are for illustrative purposes only and are not investment recommendations. Additional information, including (i) the calculation methodology; and (ii) a list showing the contribution of each holding to the portfolio’s performance during the time period will be provided upon request.
All statements made via social media sites sponsored or maintained by Enhanced Investments and its affiliates are for informational purposes only and do not constitute a comprehensive description of Enhanced Investments' investment advisory services.
Certain investments are not suitable for all investors. Before investing, consider your investment objectives and applicable fees. The rate of return on investments can vary widely over time, especially for long term investments. Investment losses are possible, including the potential loss of all amounts invested. Information provided by Enhanced Investments is for informational and general educational purposes only and is not investment or financial advice.